CN1876843A - 检测突变和/或多态性的方法 - Google Patents
检测突变和/或多态性的方法 Download PDFInfo
- Publication number
- CN1876843A CN1876843A CNA2006100803797A CN200610080379A CN1876843A CN 1876843 A CN1876843 A CN 1876843A CN A2006100803797 A CNA2006100803797 A CN A2006100803797A CN 200610080379 A CN200610080379 A CN 200610080379A CN 1876843 A CN1876843 A CN 1876843A
- Authority
- CN
- China
- Prior art keywords
- primer
- complementary strand
- nucleotide sequence
- synthetic
- starting point
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 136
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 412
- 230000000295 complement effect Effects 0.000 claims abstract description 408
- 239000002773 nucleotide Substances 0.000 claims abstract description 402
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 137
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 131
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 131
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 67
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 28
- 239000007795 chemical reaction product Substances 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims description 155
- 238000000137 annealing Methods 0.000 claims description 150
- 239000000047 product Substances 0.000 claims description 142
- 230000008859 change Effects 0.000 claims description 134
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 109
- 108020004635 Complementary DNA Proteins 0.000 claims description 79
- 108090000623 proteins and genes Proteins 0.000 claims description 73
- 238000001514 detection method Methods 0.000 claims description 59
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 54
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 54
- 238000006073 displacement reaction Methods 0.000 claims description 47
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 45
- 230000003321 amplification Effects 0.000 claims description 43
- 238000012360 testing method Methods 0.000 claims description 26
- 238000006555 catalytic reaction Methods 0.000 claims description 23
- 230000008569 process Effects 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
- 230000003750 conditioning effect Effects 0.000 claims description 13
- 238000002844 melting Methods 0.000 claims description 11
- 230000008018 melting Effects 0.000 claims description 11
- 239000000758 substrate Substances 0.000 claims description 10
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 8
- 241000282414 Homo sapiens Species 0.000 claims description 7
- 241000700605 Viruses Species 0.000 claims description 6
- 230000001717 pathogenic effect Effects 0.000 claims description 5
- 239000000427 antigen Substances 0.000 claims description 4
- 102000036639 antigens Human genes 0.000 claims description 4
- 108091007433 antigens Proteins 0.000 claims description 4
- 210000001772 blood platelet Anatomy 0.000 claims description 4
- 238000009413 insulation Methods 0.000 claims description 4
- 241000590002 Helicobacter pylori Species 0.000 claims description 3
- 241000711549 Hepacivirus C Species 0.000 claims description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- 229940037467 helicobacter pylori Drugs 0.000 claims description 3
- 210000000265 leukocyte Anatomy 0.000 claims description 3
- 201000004792 malaria Diseases 0.000 claims description 3
- 238000013519 translation Methods 0.000 claims description 3
- 241000712461 unidentified influenza virus Species 0.000 claims description 3
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 claims description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000009396 hybridization Methods 0.000 abstract description 17
- 230000035772 mutation Effects 0.000 abstract description 13
- 102000054765 polymorphisms of proteins Human genes 0.000 abstract description 4
- 108020004414 DNA Proteins 0.000 description 60
- 239000002585 base Substances 0.000 description 42
- 239000000523 sample Substances 0.000 description 35
- 230000007246 mechanism Effects 0.000 description 34
- 239000002253 acid Substances 0.000 description 33
- 230000000694 effects Effects 0.000 description 18
- 108091033319 polynucleotide Proteins 0.000 description 18
- 102000040430 polynucleotide Human genes 0.000 description 18
- 239000002157 polynucleotide Substances 0.000 description 18
- 102000004190 Enzymes Human genes 0.000 description 16
- 108090000790 Enzymes Proteins 0.000 description 16
- 238000013461 design Methods 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 11
- 101150003340 CYP2C19 gene Proteins 0.000 description 10
- 102100029363 Cytochrome P450 2C19 Human genes 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 238000010586 diagram Methods 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 108010026925 Cytochrome P-450 CYP2C19 Proteins 0.000 description 9
- 238000007397 LAMP assay Methods 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 7
- 229960005542 ethidium bromide Drugs 0.000 description 7
- 238000000018 DNA microarray Methods 0.000 description 6
- 239000012472 biological sample Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 230000036267 drug metabolism Effects 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 230000035484 reaction time Effects 0.000 description 6
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 6
- 230000002194 synthesizing effect Effects 0.000 description 6
- 101150065499 CYP2C18 gene Proteins 0.000 description 5
- 108010000543 Cytochrome P-450 CYP2C9 Proteins 0.000 description 5
- 102100029358 Cytochrome P450 2C9 Human genes 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 230000006641 stabilisation Effects 0.000 description 5
- 238000011105 stabilization Methods 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 3
- 108060002716 Exonuclease Proteins 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 102000013165 exonuclease Human genes 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 3
- 206010061623 Adverse drug reaction Diseases 0.000 description 2
- 101150053096 CYP2C9 gene Proteins 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 2
- 108091081021 Sense strand Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930003756 Vitamin B7 Natural products 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000001668 nucleic acid synthesis Methods 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 230000037432 silent mutation Effects 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 239000011735 vitamin B7 Substances 0.000 description 2
- 235000011912 vitamin B7 Nutrition 0.000 description 2
- 101150040471 19 gene Proteins 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102100029368 Cytochrome P450 2C18 Human genes 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 101000919360 Homo sapiens Cytochrome P450 2C18 Proteins 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091092878 Microsatellite Proteins 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 108020004485 Nonsense Codon Proteins 0.000 description 1
- 108010010677 Phosphodiesterase I Proteins 0.000 description 1
- 241000606651 Rickettsiales Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 101150104425 T4 gene Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 101150036080 at gene Proteins 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000003200 chromosome mapping Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 108010012052 cytochrome P-450 CYP2C subfamily Proteins 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009415 formwork Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- -1 methane amide Chemical class 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000037434 nonsense mutation Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000005477 standard model Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
Abstract
Description
Claims (26)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPPCT/JP99/06213 | 1999-11-08 | ||
PCT/JP1999/006213 WO2000028082A1 (fr) | 1998-11-09 | 1999-11-08 | Procede de synthese d'acide nucleique |
WOPCT/JP99/06213 | 1999-11-08 | ||
JP134334/00 | 2000-04-28 | ||
JP2000134334 | 2000-04-28 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN00818133A Division CN1415020A (zh) | 1999-11-08 | 2000-11-07 | 检测突变和/或多态性的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1876843A true CN1876843A (zh) | 2006-12-13 |
CN1876843B CN1876843B (zh) | 2012-09-05 |
Family
ID=14237231
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008182620A Expired - Lifetime CN100393875C (zh) | 1999-11-08 | 2000-03-28 | 合成核酸的方法 |
CN2006100803797A Expired - Lifetime CN1876843B (zh) | 1999-11-08 | 2000-11-07 | 检测突变和/或多态性的方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB008182620A Expired - Lifetime CN100393875C (zh) | 1999-11-08 | 2000-03-28 | 合成核酸的方法 |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR100612551B1 (zh) |
CN (2) | CN100393875C (zh) |
BR (1) | BR0015382B1 (zh) |
CA (1) | CA2390309C (zh) |
IL (1) | IL149446A0 (zh) |
NO (1) | NO331732B1 (zh) |
RU (1) | RU2252964C2 (zh) |
WO (1) | WO2001034790A1 (zh) |
ZA (1) | ZA200203293B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9228231B2 (en) | 2012-08-09 | 2016-01-05 | Industrial Technology Research Institute | Kit for detecting a mutation and/or polymorphism of a specific region in a target nucleotide sequence |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743605B1 (en) | 1998-06-24 | 2004-06-01 | Enzo Life Sciences, Inc. | Linear amplification of specific nucleic acid sequences |
US8445664B2 (en) | 1998-06-24 | 2013-05-21 | Enzo Diagnostics, Inc. | Kits for amplifying and detecting nucleic acid sequences |
JP4726381B2 (ja) * | 2000-04-07 | 2011-07-20 | 栄研化学株式会社 | 2本鎖核酸を鋳型とする核酸の増幅方法 |
ATE437225T1 (de) | 2000-09-19 | 2009-08-15 | Eiken Chemical | Verfahren zur polynukleotidsynthese |
KR100806680B1 (ko) * | 2003-11-21 | 2008-02-26 | 한국표준과학연구원 | Pcr용 열순환 반응기의 성능시험용 다중 pcr 조성물 |
WO2010108325A1 (zh) * | 2009-03-26 | 2010-09-30 | 厦门艾德生物医药科技有限公司 | 一种用于核酸扩增的环形引物及其应用 |
CN101671674B (zh) * | 2009-03-27 | 2010-09-22 | 郑立谋 | 一种用于核酸扩增的环形引物及其应用 |
DK3553175T3 (da) | 2013-03-13 | 2021-08-23 | Illumina Inc | Fremgangsmåde til fremstilling af et nukleinsyresekvenseringsbibliotek |
AU2014233152A1 (en) | 2013-03-15 | 2015-09-17 | Theranos Ip Company, Llc | Nucleic acid amplification |
MX365323B (es) | 2013-03-15 | 2019-05-29 | Theranos Ip Co Llc | Amplificación de ácidos nucléicos. |
ES2703792T3 (es) * | 2013-11-22 | 2019-03-12 | Orion Diagnostica Oy | Detección de ácidos nucleicos mediante amplificación basada en invasión de hebra |
WO2016011280A1 (en) | 2014-07-16 | 2016-01-21 | Tangen Biosciences, Inc. | Isothermal methods for amplifying nucleic acid samples |
WO2016061517A2 (en) * | 2014-10-17 | 2016-04-21 | Illumina Cambridge Limited | Contiguity preserving transposition |
WO2016073353A1 (en) | 2014-11-03 | 2016-05-12 | Tangen Biosciences, Inc. | Apparatus and method for cell, spore, or virus capture and disruption |
US10273534B2 (en) | 2014-12-15 | 2019-04-30 | Cepheid | Exponential base-greater-than-2 nucleic acid amplification |
WO2018132939A1 (zh) * | 2017-01-17 | 2018-07-26 | 中国科学院过程工程研究所 | 一种恒温条件下合成核酸的方法 |
WO2019051732A1 (zh) * | 2017-09-14 | 2019-03-21 | 中科芯瑞(苏州)生物科技有限公司 | 一种恒温条件下合成核酸的方法及试剂盒 |
AU2019371797A1 (en) | 2018-10-29 | 2021-05-20 | Cepheid | Exponential base-3 nucleic acid amplification with reduced amplification time using nested overlapping primers |
CN113302314A (zh) | 2019-01-15 | 2021-08-24 | 3M创新有限公司 | 用于产志贺毒素大肠杆菌(stec)检测的环介导的等温扩增引物 |
WO2021165828A1 (en) | 2020-02-17 | 2021-08-26 | 3M Innovative Properties Company | Loop-mediated isothermal amplification primers for vibrio parahaemolyticus detection and uses thereof |
CA3186580A1 (en) | 2020-06-12 | 2021-12-16 | Sherlock Biosciences, Inc. | Crispr-based sars-cov-2 detection |
CN116075596A (zh) | 2020-08-07 | 2023-05-05 | 牛津纳米孔科技公开有限公司 | 鉴定核酸条形码的方法 |
EP4105327A4 (en) * | 2021-04-29 | 2023-01-18 | Ningbo Institute of Life and Health Industry University of Chinese Academy of Sciences | PROCESS FOR THE PREPARATION OF CONSTANT TEMPERATURE NUCLEIC ACIDS AND KIT AND USE THEREOF |
CN113201583B (zh) * | 2021-04-29 | 2022-02-08 | 国科宁波生命与健康产业研究院 | 恒温条件下合成核酸的方法及试剂盒和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4213029A1 (de) * | 1991-09-26 | 1993-04-01 | Boehringer Mannheim Gmbh | Verfahren zur spezifischen vervielfaeltigung von nukleins aeuresequenzen |
ATE161586T1 (de) * | 1991-10-11 | 1998-01-15 | Behringwerke Ag | Verfahren zur herstellung eines polynukleotids zum gebrauch in ''single-primer'' amplifizierung und phosphorothioat-enthaltende oligonukleotide als primer in nukleinsäureamplifizierung |
WO1993017127A1 (en) * | 1992-02-20 | 1993-09-02 | The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University | Boomerand dna amplification |
FR2721945B1 (fr) * | 1994-07-04 | 1996-10-18 | David Fabrice | Accroissement genique, un procede d'amplicication genique isotherme et ses applications |
FR2726277B1 (fr) * | 1994-10-28 | 1996-12-27 | Bio Merieux | Oligonucleotide utilisable comme amorce dans une methode d'amplification basee sur une replication avec deplacement de brin |
EP1231281B1 (en) * | 1999-11-08 | 2006-02-01 | Eiken Kagaku Kabushiki Kaisha | Method of detecting variation or polymorphism |
-
2000
- 2000-03-28 KR KR1020027005901A patent/KR100612551B1/ko active IP Right Grant
- 2000-03-28 IL IL14944600A patent/IL149446A0/xx unknown
- 2000-03-28 RU RU2002115268/13A patent/RU2252964C2/ru active
- 2000-03-28 CA CA2390309A patent/CA2390309C/en not_active Expired - Lifetime
- 2000-03-28 WO PCT/JP2000/001919 patent/WO2001034790A1/ja active IP Right Grant
- 2000-03-28 CN CNB008182620A patent/CN100393875C/zh not_active Expired - Lifetime
- 2000-03-28 BR BRPI0015382-6A patent/BR0015382B1/pt active IP Right Grant
- 2000-11-07 CN CN2006100803797A patent/CN1876843B/zh not_active Expired - Lifetime
-
2002
- 2002-04-25 ZA ZA200203293A patent/ZA200203293B/xx unknown
- 2002-05-07 NO NO20022171A patent/NO331732B1/no not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9228231B2 (en) | 2012-08-09 | 2016-01-05 | Industrial Technology Research Institute | Kit for detecting a mutation and/or polymorphism of a specific region in a target nucleotide sequence |
TWI600766B (zh) * | 2012-08-09 | 2017-10-01 | 財團法人工業技術研究院 | 用於偵測一目標核苷酸序列中之一特定區域的一突變及/或多形性的套組 |
Also Published As
Publication number | Publication date |
---|---|
CN100393875C (zh) | 2008-06-11 |
ZA200203293B (en) | 2003-03-26 |
RU2002115268A (ru) | 2004-01-27 |
CA2390309A1 (en) | 2001-05-17 |
KR100612551B1 (ko) | 2006-08-11 |
CN1876843B (zh) | 2012-09-05 |
NO20022171L (no) | 2002-07-04 |
NO20022171D0 (no) | 2002-05-07 |
IL149446A0 (en) | 2002-11-10 |
CA2390309C (en) | 2012-09-25 |
CN1420928A (zh) | 2003-05-28 |
BR0015382A (pt) | 2002-07-02 |
NO331732B1 (no) | 2012-03-12 |
RU2252964C2 (ru) | 2005-05-27 |
KR20020064896A (ko) | 2002-08-10 |
WO2001034790A1 (fr) | 2001-05-17 |
BR0015382B1 (pt) | 2014-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1876843A (zh) | 检测突变和/或多态性的方法 | |
CN1415020A (zh) | 检测突变和/或多态性的方法 | |
CN1034673C (zh) | 检测核苷酸顺序的方法 | |
CN1222614C (zh) | 合成多核苷酸的方法 | |
CN1198943C (zh) | 通过裂解脱碱基位点的核酸产生可延伸的上游dna片段而鉴定核酸分子的方法 | |
CN100351393C (zh) | 核苷酸多态性的检测方法 | |
CN1185347C (zh) | 用于改进体外核酸合成和扩增的提升热稳定dna聚合酶保真性的热稳定酶 | |
CN1608137A (zh) | 通过同时探查和酶介导检测的多态性基因座多重分析 | |
CN101074450A (zh) | 诊断探针检测系统 | |
CN1432061A (zh) | 使用双链核酸为模板扩增核酸的方法 | |
CN1633505A (zh) | 核酸扩增方法 | |
CN1578841A (zh) | 退火控制引物及该退火控制引物的使用 | |
CN1257551A (zh) | Vntr等位基因的提取与利用 | |
CN1850981A (zh) | 切口酶扩增靶核酸序列的方法及用于扩增靶核酸序列的试剂盒及其应用 | |
CN1167794C (zh) | Dna的合成方法 | |
CN1500144A (zh) | 扩增的核酸及其固定化制品 | |
CN1665938A (zh) | 检测序列差异的方法 | |
CN1890368A (zh) | 扩增核酸的方法 | |
CN1675373A (zh) | 用于鉴别水稻品种的方法 | |
CN1250743C (zh) | 测定核酸碱基序列的方法 | |
CN1633500A (zh) | 用于持家基因mRNA检测的核酸扩增用引物和使用该引物的检查方法 | |
CN1798842A (zh) | 核酸检测 | |
CN1697883A (zh) | 靶核苷酸序列的检测方法、该方法实施中使用的检测靶结构以及其制造方法、和靶核苷酸序列检测用分析试剂盒 | |
CN1537954A (zh) | 表达基因分析方法以及用于表达基因分析的探针试剂盒 | |
CN1671841A (zh) | 基因多态性分型方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1097002 Country of ref document: HK |
|
CI01 | Publication of corrected invention patent application |
Correction item: Priority first item [33] country Correct: [33]WO False: [33]JP Number: 50 Volume: 22 |
|
CI02 | Correction of invention patent application |
Correction item: Priority first item [33] country Correct: [33]WO False: [33]JP Number: 50 Page: The title page Volume: 22 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: PRIORITY ¬ NO. 1 ¢33!¬ COUNTRY; FROM: ¢33!JP TO: ¢33!WO |
|
ERR | Gazette correction |
Free format text: CORRECT: PRIORITY ¬ NO. 1 ¢33!¬ COUNTRY; FROM: ¢33!JP TO: ¢33!WO |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1097002 Country of ref document: HK |
|
CX01 | Expiry of patent term |
Granted publication date: 20120905 |
|
CX01 | Expiry of patent term |